Concept Integration

Bone and Cartilage Tumours and Tumour-Like Lesions

Connect tumour origin, matrix production, skeletal location, clinical presentation and diagnostic interpretation for rapid revision.

1. The Topic in One Connected Flow

Bone and cartilage lesions arise from abnormal osteogenic, cartilaginous, primitive or stromal cells. Their biological behaviour changes bone matrix, cortex and surrounding tissue, producing pain, swelling, restricted movement or fracture. Diagnosis depends on connecting the patient’s age and lesion site with the matrix pattern, radiological behaviour and histopathological findings.

“`

Cause or Origin
Neoplastic mutation, gene fusion, abnormal stromal signalling or developmental defect

→

Core Mechanism
Abnormal cells produce osteoid, cartilage, fibrous tissue or osteoclast-activating signals

→

Structural Change
Matrix formation, bone destruction, cortical expansion or soft-tissue extension

→

Clinical Presentation
Pain, swelling, mass, restricted movement, fever mimic or pathological fracture

→

Diagnostic Clue
Age, epiphyseal-metaphyseal-diaphyseal location, matrix and radiological behaviour

→

Diagnostic Action
Radiography → MRI or CT when required → planned biopsy → histopathology

→

Outcome
Regression, local recurrence, fracture, local invasion or metastatic spread

“`

2. Key Clinical Connections

“`

Bone-Forming Tumours

Small cortical nidus
→
prostaglandin-rich lesion
→
nocturnal pain relieved by NSAIDs
→
osteoid osteoma

Malignant osteoid
→
destructive metaphyseal lesion
→
progressive pain and swelling
→
osteosarcoma

Ewing Sarcoma as an Infection Mimic

Child with fever and diaphyseal pain
→
destructive small round-cell tumour
→
inflammatory findings
→
possible confusion with osteomyelitis

Persistent aggressive lesion
→
imaging and tissue diagnosis
→
confirmation of Ewing sarcoma

Location and Matrix Guide Diagnosis

Epiphyseal lytic lesion after skeletal maturity
→
stromal-cell-driven osteoclast activation
→
giant-cell tumour

Cartilage matrix with cortical and medullary continuity
→
osteochondroma

“`

3. AIM High-Yield Integration Review

“`

⭐ Osteosarcoma: malignant osteoid production → aggressive metaphyseal destruction → progressive pain and swelling, commonly around the knee.

⭐ Osteoid osteoma: small cortical nidus with high prostaglandin activity → nocturnal pain → marked relief with NSAIDs.

Osteoblastoma: larger osteoid-forming lesion, often involving the spine → pain with a weaker NSAID response than osteoid osteoma.

⭐ Ewing sarcoma: diaphyseal destructive small round-cell tumour → fever and inflammatory findings → clinical mimic of osteomyelitis.

⭐ Giant-cell tumour: stromal-cell-mediated osteoclast recruitment → expansile epiphyseal lytic lesion in a skeletally mature patient.

Osteochondroma: cartilage-capped outgrowth with cortical and medullary continuity with the parent bone → characteristic radiological diagnosis.

Non-ossifying fibroma: eccentric metaphyseal lucency with a sclerotic rim in a child → developmental fibrous lesion rather than an aggressive neoplasm.

Diagnostic integration: age + skeletal compartment + matrix pattern + margin, cortex and periosteal response → most reliable interpretation before planned biopsy.

AIM Exam Trap:
Age or site alone is not enough. Combine age, exact skeletal location, matrix and radiological behaviour before selecting the diagnosis.